PG-1 demonstrates dual “antimicrobial-reparative” properties: potentially repairing infection-induced structural damage by regulating ECM–receptor interaction, balancing inflammation through cross-signaling nodes (such as NF-κB in the osteoclast differentiation pathway), and accelerating functional immune recovery by correcting transcriptional misregulation. This evidence concerns the gene NFKB1 and infection.